A detailed history of Veery Capital, LLC transactions in Thermo Fisher Scientific Inc. stock. As of the latest transaction made, Veery Capital, LLC holds 435 shares of TMO stock, worth $223,677. This represents 0.1% of its overall portfolio holdings.

Number of Shares
435
Previous 435 -0.0%
Holding current value
$223,677
Previous $240,000 12.08%
% of portfolio
0.1%
Previous 0.1%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 18, 2024

BUY
$541.52 - $599.02 $1,624 - $1,797
3 Added 0.69%
435 $240,000
Q1 2024

Apr 19, 2024

BUY
$528.82 - $599.43 $4,230 - $4,795
8 Added 1.89%
432 $251,000
Q4 2023

Jan 10, 2024

SELL
$431.41 - $532.94 $5,608 - $6,928
-13 Reduced 2.97%
424 $225,000
Q3 2023

Oct 13, 2023

SELL
$498.29 - $574.41 $3,488 - $4,020
-7 Reduced 1.58%
437 $221,000
Q2 2023

Jul 13, 2023

BUY
$508.46 - $591.13 $11,694 - $13,595
23 Added 5.46%
444 $231,000
Q1 2023

Apr 13, 2023

SELL
$535.0 - $604.82 $535 - $604
-1 Reduced 0.24%
421 $242,000
Q4 2022

Jan 17, 2023

BUY
$484.71 - $571.37 $484 - $571
1 Added 0.24%
422 $0
Q3 2022

Oct 12, 2022

SELL
$507.19 - $604.49 $507 - $604
-1 Reduced 0.24%
421 $214,000
Q2 2022

Jul 18, 2022

BUY
$500.9 - $612.21 $3,005 - $3,673
6 Added 1.44%
422 $229,000
Q1 2022

Apr 18, 2022

SELL
$524.0 - $644.92 $9,956 - $12,253
-19 Reduced 4.37%
416 $246,000
Q3 2021

Oct 13, 2021

SELL
$509.53 - $609.78 $13,247 - $15,854
-26 Reduced 5.64%
435 $249,000
Q2 2021

Jul 14, 2021

SELL
$441.0 - $508.24 $7,056 - $8,131
-16 Reduced 3.35%
461 $233,000
Q1 2021

Apr 28, 2021

SELL
$439.85 - $518.83 $16,274 - $19,196
-37 Reduced 7.2%
477 $218,000
Q4 2020

Feb 08, 2021

BUY
$435.06 - $527.66 $223,620 - $271,217
514 New
514 $239,000

Others Institutions Holding TMO

About THERMO FISHER SCIENTIFIC INC.


  • Ticker TMO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 391,788,992
  • Market Cap $201B
  • Description
  • Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...
More about TMO
Track This Portfolio

Track Veery Capital, LLC Portfolio

Follow Veery Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Veery Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Veery Capital, LLC with notifications on news.